The Association of Infrared Imaging Findings of the Breast with Hormone Receptor and Human Epidermal Growth Factor Receptor 2 Status of Breast Cancer

Academic Radiology

Volumn 18, Issue 2, 2011, Pages 212-219

  Wang, Jane ^a,b   Shih, Tiffany Ting Fang ^a,b   Yen, Ruoh Fang ^a,b   Lu, Yen Shen ^a   Chen, Chin Yu ^c   Mao, Tsui Lien ^a   Lin, Ching Hung ^a   Kuo, Wen Hung ^a   Tsai, Yuh Show ^d   Chang, King Jen ^a   Chien, Kuo Liong ^e  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Breast neoplasm; Estrogen receptor; Human epidermal growth factor receptor 2; Infrared imaging; Progesterone receptor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ARTICLE; BREAST; BREAST CANCER; CANCER LOCALIZATION; CONTROLLED STUDY; FEMALE; FISHER EXACT TEST; HUMAN; INFRARED RADIATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; THERMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; THERMOGRAPHY;

EID: 78651108145     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2010.09.016     Document Type: Article

References (36)

1. Uematsu T., Kasami M., Yuen S. Triple-negative breast cancer: correlation between MR imaging and pathologic findings. Radiology 2009, 250:638-647.
2. Wang Y., Ikeda D.M., Narasimhan B., et al. Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression. Radiology 2008, 246:367-375.
3. Makkat S., Luypaert R., Stadnik T., et al. Deconvolution-based dynamic contrast-enhanced MR imaging of breast tumors: correlation of tumor blood flow with human epidermal growth factor receptor 2 status and clinicopathologic findings-preliminary results. Radiology 2008, 249:471-482.
4. Karamouzis M.V., Konstantinopoulos P.A., Papavassiliou A.G. ErbB/HER receptor family in breast cancer-the more we search the more we learn. Ann Oncol 2008, 19:1020-1021.
5. Chen J.H., Nalcioglu O., Su M.Y. MR imaging features of invasive breast cancer correlated with hormonal receptors: does progesterone receptor matter?. Ann Oncol 2008, 19:1024-1026.
6. Katrina R.B., Monica B., Rosemary D.C., et al. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype. Cancer 2007, 109:1721-1728.
7. Konecny G.E., Meng Y.G., Untch M., et al. Association between HER-2/neu and vascular endothelial growth factor expression predicts clinical outcome in primary breast cancer patients. Clin Cancer Res 2004, 10:1706-1716.
8. Blackwell K.L., Dewhirst M.W., Liotcheva V., et al. HER-2 Gene amplification correlates with higher levels of angiogenesis and lower levels of hypoxia in primary breast tumors. Clin Cancer Res 2004, 10:4083-4088.
9. Konecny G., Pauletti G., Pegram M., et al. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. J Natl Cancer Inst 2003, 95:142-153.
10. Kumar R., Yarmand-Bagheri R. The role of HER2 in angiogenesis. Semin Oncol 2001, 28:27-32.
11. Mavi A., Cermik T.F., Urhan M., et al. The effects of estrogen, progesterone, and C-erbB-2 receptor states on 18F-FDG uptake of primary breast cancer lesions. J Nucl Med 2007, 48:1266-1272.
12. Bo Kyoung S., Etta D.P., Cherie M.K., et al. Correlation of HER-2/neu overexpression with mammography and age distribution in primary breast carcinomas. Acad Radiol 2006, 13:1211-1218.
13. Ng E.Y., Ung L.N., Ng F.C., et al. Statistical analysis of healthy and malignant breast thermography. J Med Eng Technol 2001, 25:253-263.
14. Foster K.R. Thermographic detection of breast cancer. IEEE Eng Med Biol Mag 1998, 17:10-14.
15. Hobbins W.B. Thermography of the breast-a skin organ. Thermal assessment of breast health 1983, 37-48. MTP Press, Lancaster, United Kingdom. M. Gautherie, E. Albert, L. Keith (Eds.).
16. Wang J., Chang K.J., Chen C.Y., et al. Evaluation of the diagnostic performance of infrared imaging of the breast: a preliminary study. Biomed Eng Online 2010, 9:3.
17. Parisky Y.R., Sardi A., Hamm R., et al. Efficacy of computerized infrared imaging analysis to evaluate mammographically suspicious lesions. AJR Am J Roentgenol 2003, 180:263-269.
18. Ng E.Y., Fok S.C., Peh Y.C., et al. Computerized detection of breast cancer with artificial intelligence and thermograms. J Med Eng Technol 2002, 26:152-157.
19. Head J.F., Wang F., Lipari C.A., et al. The important role of infrared imaging in breast cancer. IEEE Eng Med Biol Mag 2000, 19:52-57.
20. Ng E.Y.K., Kee E.C. Advanced integrated technique in breast cancer thermography. J Med Eng Technol 2008, 32:103-114.
21. Arora N., Martins D., Ruggerio D., et al. Effectiveness of a noninvasive digital infrared thermal imaging system in the detection of breast cancer. Am J Surg 2008, 196:523-526.
22. Keyserlingk J.R., Ahlgren P.D., Yu E., et al. Infrared imaging of the breast: initial reappraisal using high-resolution digital technology in 100 successive cases of stage I and II breast cancer. Breast J 1998, 4:245-251.
23. Ohsumi S., Takashima S., Aogi K., et al. Prognostic value of thermographical findings in patients with primary breast cancer. Breast Cancer Res Treat 2002, 74:213-220.
24. Head J.F., Wang F., Elliott R.L. Breast thermography is a noninvasive prognostic procedure that predicts tumor growth rate in breast cancer patients. Ann N Y Acad Sci 1993, 698:153-158.
25. Isard H.J., Sweitzer C.J., Edelstein G.R. Breast thermography. A prognostic indicator for breast cancer survival. Cancer 1988, 62:484-488.
26. Gautherie M. Improved system for the objective evaluation of breast thermograms. Prog Clin Biol Res 1982, 107:897-905.
27. Isard H.J. Thermographic "edge sign" in breast carcinoma. Cancer 1972, 30:957-963.
28. Greene F., Page D., Fleming I., et al. AJCC cancer staging manual 2002, Springer, New York.
29. Lin C.H., Lien H.C., Hu F.C., et al. Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy. J Zhejiang Univ Sc B 2010, 11:1-9.
30. Lin C.H., Liau J.Y., Lu Y.S., et al. Molecular subtypes of breast cancer emerging in young women in Taiwan: evidence for more than just westernization as a reason for the disease in Asia. Cancer Epidemiol Biomarker Prevent 2009, 18:1807-1814.
31. Ng E.Y.K., Chen Y., Ung L.N. Computerized breast thermography: study of image segmentation and temperature cyclic variations. J Med Eng Technol 2001, 25:12-16.
32. Xie W., McCahon P., Jakobsen K., et al. Evaluation of the ability of digital infrared imaging to detect vascular changes in experimental animal tumours. Int J Cancer 2004, 108:790-794.
33. Swaminathan S., Horn T.D., Pellowski D., et al. Nephrogenic systemic fibrosis, gadolinium, and iron mobilization. N Engl J Med 2007, 357:720-722.
34. Broome D.R., Girguis M.S., Baron P.W., et al. Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned. AJR Am J Roentgenol 2007, 188:586-592.
35. Jiang L., Zhan W., Loew M.H. Dynamic thermal modeling of the normal and tumorous breast under elastic deformation. Med Image Comput Computer Assist Interv 2008, 798-805.
36. Ng E.Y.K., Sudharsan N.M. An improved three-dimensional direct numerical modelling and thermal analysis of a female breast with tumour. J Eng Med 2001, 215:25-37.